BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 1513375)

  • 1. In vitro toxicology of fumonisins and the mechanistic implications.
    Norred WP; Wang E; Yoo H; Riley RT; Merrill AH
    Mycopathologia; 1992 Feb; 117(1-2):73-8. PubMed ID: 1513375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fumonisin inhibition of de novo sphingolipid biosynthesis and cytotoxicity are correlated in LLC-PK1 cells.
    Yoo HS; Norred WP; Wang E; Merrill AH; Riley RT
    Toxicol Appl Pharmacol; 1992 May; 114(1):9-15. PubMed ID: 1585377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated sphingoid bases and complex sphingolipid depletion as contributing factors in fumonisin-induced cytotoxicity.
    Yoo HS; Norred WP; Showker J; Riley RT
    Toxicol Appl Pharmacol; 1996 Jun; 138(2):211-8. PubMed ID: 8658522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of sphingolipid biosynthesis by fumonisins. Implications for diseases associated with Fusarium moniliforme.
    Wang E; Norred WP; Bacon CW; Riley RT; Merrill AH
    J Biol Chem; 1991 Aug; 266(22):14486-90. PubMed ID: 1860857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fumonisin B1 inhibits sphingosine (sphinganine) N-acyltransferase and de novo sphingolipid biosynthesis in cultured neurons in situ.
    Merrill AH; van Echten G; Wang E; Sandhoff K
    J Biol Chem; 1993 Dec; 268(36):27299-306. PubMed ID: 8262970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of sphingolipid biosynthesis in rat primary hepatocyte cultures by fumonisin B1 and other structurally related compounds.
    van der Westhuizen L; Shephard GS; Snyman SD; Abel S; Swanevelder S; Gelderblom WC
    Food Chem Toxicol; 1998 Jun; 36(6):497-503. PubMed ID: 9674957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mycotoxin-induced elevation of free sphingoid bases in precision-cut rat liver slices: specificity of the response and structure-activity relationships.
    Norred WP; Plattner RD; Dombrink-Kurtzman MA; Meredith FI; Riley RT
    Toxicol Appl Pharmacol; 1997 Nov; 147(1):63-70. PubMed ID: 9356308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disruption of sphingolipid metabolism and stimulation of DNA synthesis by fumonisin B1. A molecular mechanism for carcinogenesis associated with Fusarium moniliforme.
    Schroeder JJ; Crane HM; Xia J; Liotta DC; Merrill AH
    J Biol Chem; 1994 Feb; 269(5):3475-81. PubMed ID: 8106389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sphingoid bases and their phosphates: transient activation and delayed repression of protein kinase C isoforms and their possible involvement in fumonisin B1 cytotoxicity.
    Gopee NV; Sharma RP
    Toxicology; 2003 May; 187(2-3):239-50. PubMed ID: 12699912
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fumonisin toxicity and sphingolipid biosynthesis.
    Merrill AH; Wang E; Vales TR; Smith ER; Schroeder JJ; Menaldino DS; Alexander C; Crane HM; Xia J; Liotta DC; Meredith FI; Riley RT
    Adv Exp Med Biol; 1996; 392():297-306. PubMed ID: 8850625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of proliferation in the toxicity of fumonisin B1: enhanced hepatotoxic response in the partially hepatectomized rat.
    Li W; Riley RT; Voss KA; Norred WP
    J Toxicol Environ Health A; 2000 Aug; 60(7):441-57. PubMed ID: 12607906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early fumonisin B1 toxicity in relation to disrupted sphingolipid metabolism in male BALB/c mice.
    Tsunoda M; Sharma RP; Riley RT
    J Biochem Mol Toxicol; 1998; 12(5):281-9. PubMed ID: 9664234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fumonisin B(1) induces apoptosis in LLC-PK(1) renal epithelial cells via a sphinganine- and calmodulin-dependent pathway.
    Kim MS; Lee DY; Wang T; Schroeder JJ
    Toxicol Appl Pharmacol; 2001 Oct; 176(2):118-26. PubMed ID: 11601888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fumonisin-induced tumor necrosis factor-alpha expression in a porcine kidney cell line is independent of sphingoid base accumulation induced by ceramide synthase inhibition.
    He Q; Riley RT; Sharma RP
    Toxicol Appl Pharmacol; 2001 Jul; 174(1):69-77. PubMed ID: 11437650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toxicology and carcinogenesis studies of fumonisin B1 (cas no. 116355-83-0) in F344/N rats and B6C3F1 mice (feed studies).
    Natl Toxicol Program Tech Rep Ser; 2001 Dec; (496):1-352. PubMed ID: 11852482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dietary fumonisin B1 induces disruption of sphingolipid metabolism in Sprague-Dawley rats: a new mechanism of nephrotoxicity.
    Riley RT; Hinton DM; Chamberlain WJ; Bacon CW; Wang E; Merrill AH; Voss KA
    J Nutr; 1994 Apr; 124(4):594-603. PubMed ID: 8145083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alteration of tissue and serum sphinganine to sphingosine ratio: an early biomarker of exposure to fumonisin-containing feeds in pigs.
    Riley RT; An NH; Showker JL; Yoo HS; Norred WP; Chamberlain WJ; Wang E; Merrill AH; Motelin G; Beasley VR
    Toxicol Appl Pharmacol; 1993 Jan; 118(1):105-12. PubMed ID: 8430417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential effects of fumonisin B1 on cell death in cultured cells: the significance of the elevated sphinganine.
    Yu CH; Lee YM; Yun YP; Yoo HS
    Arch Pharm Res; 2001 Apr; 24(2):136-43. PubMed ID: 11339633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An overview of rodent toxicities: liver and kidney effects of fumonisins and Fusarium moniliforme.
    Voss KA; Riley RT; Norred WP; Bacon CW; Meredith FI; Howard PC; Plattner RD; Collins TF; Hansen DK; Porter JK
    Environ Health Perspect; 2001 May; 109 Suppl 2(Suppl 2):259-66. PubMed ID: 11359694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence for disruption of sphingolipid metabolism as a contributing factor in the toxicity and carcinogenicity of fumonisins.
    Riley RT; Wang E; Schroeder JJ; Smith ER; Plattner RD; Abbas H; Yoo HS; Merrill AH
    Nat Toxins; 1996; 4(1):3-15. PubMed ID: 8680751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.